Insulin Delivery – Pipeline Products by Stage of Development 19
Insulin Delivery – Pipeline Products by Segment 20
Insulin Delivery – Pipeline Products by Territory 21
Insulin Delivery – Pipeline Products by Regulatory Path 22
Insulin Delivery – Pipeline Products by Estimated Approval Date 23
Insulin Delivery – Ongoing Clinical Trials 24
Insulin Delivery Companies – Pipeline Products by Stage of Development 25
Insulin Delivery – Pipeline Products by Stage of Development 28
Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 31
Freestyle Libre Connected Insulin Pen – Product Status 31
Freestyle Libre Connected Insulin Pen – Product Description 31
Aerami Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Dance-501 – Product Status 32
Dance-501 – Product Description 32
Alshifa Medical Syringes Manufacturing Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
ALSHIFA Insulin Safety Syringe – Product Status 33
ALSHIFA Insulin Safety Syringe – Product Description 33
American Chemical Society Pipeline Products & Ongoing Clinical Trials Overview 34
Mucoadhesive Insulin Patch – Product Status 34
Mucoadhesive Insulin Patch – Product Description 34
AMF Medical SA Pipeline Products & Ongoing Clinical Trials Overview 35
Sigi Patch Pump – Product Status 35
Sigi Patch Pump – Product Description 35
Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 36
Amrita Insulin Pump – Product Status 36
Amrita Insulin Pump – Product Description 36
Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Gaia Med Diamond Semi-Disposable Pump – Product Status 37
Gaia Med Diamond Semi-Disposable Pump – Product Description 37
Gemini Pump – Product Status 38
Gemini Pump – Product Description 38
Animas Corp Pipeline Products & Ongoing Clinical Trials Overview 39
Hypoglycemia-Hyperglycemia Minimizer System – Product Status 39
Hypoglycemia-Hyperglycemia Minimizer System – Product Description 39
ASTI Corp Pipeline Products & Ongoing Clinical Trials Overview 40
Plastic Microneedle System – Product Status 40
Plastic Microneedle System – Product Description 40
Avecho Biotechnology Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
TPM – Insulin Patch – Product Status 41
TPM – Insulin Patch – Product Description 41
Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Bigfoot Certainty – Product Status 42
Bigfoot Certainty – Product Description 42
Biocon Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
Semglee Prefilled Pen – Product Status 43
Semglee Prefilled Pen – Product Description 43
Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
KiCoPen – Product Status 44
KiCoPen – Product Description 44
Cellnovo Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45
Wireless Insulin Pump System Integrated With inControl AP – Product Status 45
Wireless Insulin Pump System Integrated With inControl AP – Product Description 45
Companion Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 46
Smart Insulin Pen – Advanced Decision Support – Product Status 46
Smart Insulin Pen – Advanced Decision Support – Product Description 46
ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 47
Infusion Set – Tandem Mobi – Product Status 47
Infusion Set – Tandem Mobi – Product Description 47
Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 48
JewelPump – Product Status 48
JewelPump – Product Description 48
JewelPUMP2 – Product Status 49
JewelPUMP2 – Product Description 49
Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview 50
ExOlin – Product Status 50
ExOlin – Product Description 50
Defymed SAS – Ongoing Clinical Trials Overview 51
ExOlin – An Open Label, Monocentric, Pilot Study Evaluating Safety of ExOlin in Patients with Poorly Controlled Type 1 Diabetes with High Glucose Fluctuations, Prone to Severe Hypoglycemia 52
Dermisonics Inc Pipeline Products & Ongoing Clinical Trials Overview 53
U-Strip – Product Status 53
U-Strip – Product Description 53
Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 54
AIR Insulin System – Product Status 54
AIR Insulin System – Product Description 54
BASAGLAR Tempo Pen – Product Status 55
BASAGLAR Tempo Pen – Product Description 55
Connected Care Pre-Filled Insulin Pen – Product Status 55
Connected Care Pre-Filled Insulin Pen – Product Description 56
Embecta Corp Pipeline Products & Ongoing Clinical Trials Overview 57
Extended Wear Insulin Infusion Set – Product Status 57
Extended Wear Insulin Infusion Set – Product Description 57
Type 2 Patch Pump – Product Status 58
Type 2 Patch Pump – Product Description 58
Emperra GmbH E-Health Technologies Pipeline Products & Ongoing Clinical Trials Overview 59
ESYSTA BT Pen – Product Status 59
ESYSTA BT Pen – Product Description 59
EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 60
EOPancreas System – Product Status 60
EOPancreas System – Product Description 60
Erech Finance Cahalacha Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
Long Acting Insulin Therapy Device – Product Status 61
Long Acting Insulin Therapy Device – Product Description 61
GO-Pen ApS Pipeline Products & Ongoing Clinical Trials Overview 62
GO-Pen – Product Status 62
GO-Pen – Product Description 62
Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 63
Integrated Symbiq/EndoTool System – Product Status 63
Integrated Symbiq/EndoTool System – Product Description 63
Houston Methodist Research Institute Pipeline Products & Ongoing Clinical Trials Overview 64
NICHE – Product Status 64
NICHE – Product Description 64
Imagine Medical Device Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
Insulin Syringe – Product Status 65
Insulin Syringe – Product Description 65
InsuLenz Pipeline Products & Ongoing Clinical Trials Overview 66
Smart Polymer Contact Lens – Product Status 66
Smart Polymer Contact Lens – Product Description 66
Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 67
Omnipod 5 (Omnipod Horizon Hybrid Closed Loop System) – Product Status 67
Omnipod 5 (Omnipod Horizon Hybrid Closed Loop System) – Product Description 68
Omnipod GO – Product Status 68
Omnipod GO – Product Description 68
Omnipod U-200 Insulin Management System – Product Status 69
Omnipod U-200 Insulin Management System – Product Description 69
Omnipod U-500 Insulin Management System – Product Status 69
Omnipod U-500 Insulin Management System – Product Description 70
Insulet Corp – Ongoing Clinical Trials Overview 71
Omnipod 5 (Omnipod Horizon Hybrid Closed Loop System) – Efficacy and Safety of the Omnipod 5 System Compared to Pump Therapy in the Treatment of Type 1 Diabetes: A Randomized, Parallel-Group Clinical Trial 72
Omnipod 5 (Omnipod Horizon Hybrid Closed Loop System) – Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Patients with Type 1 Diabetes 72
Omnipod 5 (Omnipod Horizon Hybrid Closed Loop System) – Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT) 72
Omnipod 5 (Omnipod Horizon Hybrid Closed Loop System) – Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults with Type 2 Diabetes 73
Iowa State University Pipeline Products & Ongoing Clinical Trials Overview 74
Feed Forward Insulin Delivery System – Product Status 74
Feed Forward Insulin Delivery System – Product Description 74
Kailian Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 75
InnoPen Electric Insulin Pen – Product Status 75
InnoPen Electric Insulin Pen – Product Description 75
InnoTouch Insulin Application Pump – Product Status 76
InnoTouch Insulin Application Pump – Product Description 76
Le Pump Insulin Pump II – Product Status 76
Le Pump Insulin Pump II – Product Description 76
Lenomed ATA-I-1-0 Insulin Pump – Product Status 77
Lenomed ATA-I-1-0 Insulin Pump – Product Description 77
LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 78
ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Status 78
ONETOUCH Ping Verio Insulin Pump With Meter Remote – Product Description 78
MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview 79
Afrezza – Pediatric Use – Product Status 79
Afrezza – Pediatric Use – Product Description 79
Afrezza Inhaler – Product Status 80
Afrezza Inhaler – Product Description 80
MannKind Corp – Ongoing Clinical Trials Overview 81
Afrezza Inhaler – INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes 82
Medical International Technologies (Mit Canada) Inc Pipeline Products & Ongoing Clinical Trials Overview 83
Med-Jet MIT-P-I – Product Status 83
Med-Jet MIT-P-I – Product Description 83
Medicsensors SL Pipeline Products & Ongoing Clinical Trials Overview 84
Insulin Smartpatch – Product Status 84
Insulin Smartpatch – Product Description 84
MedPro Safety Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
Insulin Guard Self-Injector Safety Needle – Product Status 85
Insulin Guard Self-Injector Safety Needle – Product Description 85
MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
Freehand Patch Pump – Product Status 86
Freehand Patch Pump – Product Description 86
Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 87
Insulin Delivery System – Product Status 87
Insulin Delivery System – Product Description 87
Minimed 780G – Adults – Product Status 88
Minimed 780G – Adults – Product Description 88
Medtronic MiniMed Inc – Ongoing Clinical Trials Overview 89
Minimed 780G – Adults – Advanced Hybrid Closed-Loop Treatment in Adults with Type 1 Diabetes Not Meeting Glycaemic Targets: A Randomized Controlled Trial – The Steno 780G Study 91
Minimed 780G – Adults – Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis 91
Minimed 780G – Adults – Closed-Loop Insulin Delivery in Pregnant Women with Type 1 Diabetes 91
Minimed 780G – Adults – Closed-loop Insulin Delivery in Pregnant Women with Type 1 Diabetes: A Randomized Controlled Trial: The CRISTAL Study 92
Minimed 780G – Adults – Comparison With Observational Methods and Performance Assessment From Real-life Experience of Closed-Loop Insulin Delivery Systems 92
Minimed 780G – Adults – Effect of Advanced Automated Insulin Delivery on Glycaemia in Children and Young Adults with Type 1 Diabetes and High-risk Glycemic Control 92
Minimed 780G – Adults – Effect of an Artificial Pancreas System on Glycemic Control in Patients With Type 1 Diabetes 93
Minimed 780G – Adults – Effect of Automated Insulin Delivery with Advanced Closed-loop on Glucose Outcomes and Early-stage Diabetic Complications 93
Minimed 780G – Adults – Evaluation of the MiniMed 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp (Insulin Aspart Injection) 93
Minimed 780G – Adults – Feasibility Study for a Medtronic next Generation Hybrid Closed Loop System in Adults with Type 1 Diabetes 94
Minimed 780G – Adults – In-Home Study With MiniMed 780G Pump Automated Control in Type 2 – Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes 94
Minimed 780G – Adults – Open-label, Randomized, Controlled Clinical Trial to Evaluate the Efficacy of the Smart Insulin Pen Associated With a Continuous Glucose Monitoring System Compared to a Closed Loop System in Patients With Type 1 Diabetes (EBIACE-1) 94
Minimed 780G – Adults – Safety and Effectiveness Evaluation of the MiniMed 780G System Used in Combination With the DS5 CGM 95
Minimed 780G – Adults – Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects 95
Minimed 780G – Adults – Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev Insulin Lispro-aabc 95
Minimed 780G – Adults – The Impact of Daily CarboHydrate Intake on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-loop System (Medtronic MiniMed 780G): a Multi-center Real-world Observational Study 96
Minimed 780G – Adults – Transition of Patients with T1D From Multiple Daily Injection (MDI) and Self-monitoring of Blood Glucose (SMBG) Directly to MiniMed 780G Advanced Hybrid Closed Loop (AHCL) System :Impact on Glucose Control and Quality of Life Measures 96
Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 97
EOPatch Wearable Insulin Pump System – Product Status 97
EOPatch Wearable Insulin Pump System – Product Description 98
Implantable Insulin Pump – Product Status 98
Implantable Insulin Pump – Product Description 98
MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 99
Angel Touch – Product Status 99
Angel Touch – Product Description 99
La Fenice Pen – Product Status 100
La Fenice Pen – Product Description 100
La Fenice V – Product Status 100
La Fenice V – Product Description 100
MicroTech Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101
Equil Insulin Pump – Child and Adolescent Use – Product Status 101
Equil Insulin Pump – Child and Adolescent Use – Product Description 101
Second-Generation Patch Insulin Pump System – Product Status 102
Second-Generation Patch Insulin Pump System – Product Description 102
Modular Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 103
MODD1 (MODD Pivot) – Product Status 103
MODD1 (MODD Pivot) – Product Description 103
MODD1+ – Product Status 104
MODD1+ – Product Description 104
NanoDerma Ltd Pipeline Products & Ongoing Clinical Trials Overview 105
Intranasal Insulin Delivery Device – Product Status 105
Intranasal Insulin Delivery Device – Product Description 105
nGageIT Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview 106
InsuloSenz – Product Status 106
InsuloSenz – Product Description 106
Nitto Denko Corp Pipeline Products & Ongoing Clinical Trials Overview 107
PassPort Transdermal Basal Insulin Patch – 12 Hours – Product Status 107
PassPort Transdermal Basal Insulin Patch – 12 Hours – Product Description 107
PassPort Transdermal Basal Insulin Patch – 24 Hours – Product Status 108
PassPort Transdermal Basal Insulin Patch – 24 Hours – Product Description 108
North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 109
Pulsatile Noninvasive Drug Delivery System – Product Status 109
Pulsatile Noninvasive Drug Delivery System – Product Description 109
Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview 110
AERx iDMS – Product Status 110
AERx iDMS – Product Description 111
Ingestible SOMA – Product Status 111
Ingestible SOMA – Product Description 111
LUMI Device – Product Status 112
LUMI Device – Product Description 112
NuGen Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 113
InsuJet – Product Status 113
InsuJet – Product Description 113
Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 114
Nanobot Based Insulin Pumping Device – Product Status 114
Nanobot Based Insulin Pumping Device – Product Description 114
Perikinetics Inc Pipeline Products & Ongoing Clinical Trials Overview 115
PK Insulin Delivery Conduit – Product Status 115
PK Insulin Delivery Conduit – Product Description 115
Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 116
Ambulatory Diabetes Pump – Product Status 116
Ambulatory Diabetes Pump – Product Description 116
PhysioLogic Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 117
ThinPump – Product Status 117
ThinPump – Product Description 117
PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 118
Insulin Tracker – Product Status 118
Insulin Tracker – Product Description 118
Prometheon Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 119
TruePatch – Basal Insulin – Product Status 119
TruePatch – Basal Insulin – Product Description 119
TruePatch – Rapid-Acting (Bolus) Insulin – Product Status 120
TruePatch – Rapid-Acting (Bolus) Insulin – Product Description 120
Qlibrium Inc Pipeline Products & Ongoing Clinical Trials Overview 121
QForma – Product Status 121
QForma – Product Description 121
Sanofi Pipeline Products & Ongoing Clinical Trials Overview 122
Fix-Flex Device – Product Status 122
Fix-Flex Device – Product Description 122
SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 123
Dual ePump – Product Status 123
Dual ePump – Product Description 123
Open-Protocol Patch Pump System – Product Status 124
Open-Protocol Patch Pump System – Product Description 124
PANDA – Product Status 124
PANDA – Product Description 125
Pod Automated Insulin Delivery Device – Product Status 125
Pod Automated Insulin Delivery Device – Product Description 125
Sooil Development Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 126
Dana-I Pump – Product Status 126
Dana-I Pump – Product Description 126
Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 127
Spring Zone Hybrid Patch Pump – Product Status 127
Spring Zone Hybrid Patch Pump – Product Description 127
Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 128
CSII Catheter – Product Status 128
CSII Catheter – Product Description 129
SteadiSet Infusion Set – Product Status 129
SteadiSet Infusion Set – Product Description 129
t:slim X3 Insulin Pump – Product Status 130
t:slim X3 Insulin Pump – Product Description 130
Tandem Mobi Insulin Pump With Interoperable Technology – Product Status 130
Tandem Mobi Insulin Pump With Interoperable Technology – Product Description 131
Tandem Mobi: Tubeless – Product Status 131
Tandem Mobi: Tubeless – Product Description 131
Tandem Patch – Product Status 132
Tandem Patch – Product Description 132
Tandem Diabetes Care Inc – Ongoing Clinical Trials Overview 133
CSII Catheter – A Pilot Study for the Systematic Evaluation of the Inflammatory Response to Commercially Available Insulin Infusion Catheters in Subcutaneous Adipose Tissue 134
SteadiSet Infusion Set – A Pivotal, Non-randomized, Prospective and Single Arm Study to Evaluate SteadiFlow Seven-day-wear Infusion Set Technology in Type I Diabetes Subjects 135
TempraMed Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 136
VIVI Cap Smart – Product Status 136
VIVI Cap Smart – Product Description 136
Thermalin Inc Pipeline Products & Ongoing Clinical Trials Overview 137
Insulin Patch – Product Status 137
Insulin Patch – Product Description 137
Stabilized and Ultra-Rapid Insulin Pump – Product Status 138
Stabilized and Ultra-Rapid Insulin Pump – Product Description 138
StampPump – Product Status 138
StampPump – Product Description 139
Ultra-Rapid Highly-Concentrated Insulin Pump – Product Status 139
Ultra-Rapid Highly-Concentrated Insulin Pump – Product Description 139
Transdermal Specialties Inc Pipeline Products & Ongoing Clinical Trials Overview 140
U-Strip Insulin Patch – Product Status 140
U-Strip Insulin Patch – Product Description 140
Triple Jump Israel Ltd Pipeline Products & Ongoing Clinical Trials Overview 141
Insulin Patch Pump – Product Status 141
Insulin Patch Pump – Product Description 141
University of KwaZulu-Natal Pipeline Products & Ongoing Clinical Trials Overview 142
Pectin Insulin Gel Skin Patch – Product Status 142
Pectin Insulin Gel Skin Patch – Product Description 142
University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 143
Smart Gluco – Product Status 143
Smart Gluco – Product Description 143
University of Massachusetts Amherst Pipeline Products & Ongoing Clinical Trials Overview 144
Insulin Delivery System – Product Status 144
Insulin Delivery System – Product Description 144
University of Missouri-Kansas City Pipeline Products & Ongoing Clinical Trials Overview 145
Light Activated Insulin Depot – Product Status 145
Light Activated Insulin Depot – Product Description 145
University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview 146
Smart Cell Patch – Product Status 146
Smart Cell Patch – Product Description 146
Smart Insulin Patch – Product Status 147
Smart Insulin Patch – Product Description 147
University of Toronto Pipeline Products & Ongoing Clinical Trials Overview 148
Implantable Closed-Loop Insulin Delivery Device – Product Status 148
Implantable Closed-Loop Insulin Delivery Device – Product Description 148
Univlabs Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 149
Wearable Insulin Patch Pump – Product Status 149
Wearable Insulin Patch Pump – Product Description 149
Unomedical a/s Pipeline Products & Ongoing Clinical Trials Overview 150
Extended Infusion Set – Product Status 150
Extended Infusion Set – Product Description 150
Valeritas Inc Pipeline Products & Ongoing Clinical Trials Overview 151
V-Go Prefill Device – Product Status 151
V-Go Prefill Device – Product Description 151
V-Go SIM – Product Status 152
V-Go SIM – Product Description 152
ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 153
Kaleido Insulin Pump – Children And Adolescent – Product Status 153
Kaleido Insulin Pump – Children And Adolescent – Product Description 153
Vigmed Holding AB Pipeline Products & Ongoing Clinical Trials Overview 154
Insulin Needle – Product Status 154
Insulin Needle – Product Description 154
Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 155
NICE Device – Product Status 155
NICE Device – Product Description 155
Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 156
Integrated Automated Insulin Delivery (AID) System – Product Status 156
Integrated Automated Insulin Delivery (AID) System – Product Description 157
Lanzi – Product Status 157
Lanzi – Product Description 157
Mylife Dose – Product Status 158
Mylife Dose – Product Description 158
mylife YpsoPod Insulin Pump – Tubeless – Product Status 158
mylife YpsoPod Insulin Pump – Tubeless – Product Description 159
mylife YpsoPump – Product Status 159
mylife YpsoPump – Product Description 159
Ypsomed Holding AG – Ongoing Clinical Trials Overview 160
mylife YpsoPump – An Open-label, Multi-center, Randomized, Two Arm Single Period Parallel Study to Assess the Efficacy, Safety and Utility of Hybrid Closed-loop Glucose Control Compared to Standard Insulin Therapy Combined with Continuous Glucose Monitoring in Young People (Greater Than or Equal to 16 Years) and Adults with Cystic Fibrosis Related Diabetes (Cl4p-cf Study) 161
mylife YpsoPump – Feasibility of Automated Insulin Delivery with an Interoperable Algorithm Using an Alternative Insulin Pump 161
mylife YpsoPump – First in Human Feasibility Study; Automated Insulin Delivery Utilizing the Dexcom Next Generation Algorithm in Adults with Type 1 Diabetes 162
Integrated Automated Insulin Delivery (AID) System – Randomized Open Label Clinical Trial Examining the Safety and Efficacy of the Android Artificial Pancreas System (AAPS) with Advanced Bolus-free Features in Adults with Type 1 Diabetes 163
Zealand Pharma AS Pipeline Products & Ongoing Clinical Trials Overview 164
HyoPen – Product Status 164
HyoPen – Product Description 164
HypoPal Rescue Pen – Product Status 165
HypoPal Rescue Pen – Product Description 165
V-Go Wearable Insulin Delivery Device – Product Status 165
V-Go Wearable Insulin Delivery Device – Product Description 166
Zenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 167
Smart Insulin Patch – Product Status 167
Smart Insulin Patch – Product Description 167
Glossary 253
